Hey StLX. Great post. You have captured the motives of the Insurance companies correctly IMO, which is important in determining ROI. I agree with all that you said but understand that stem cell multiplication is the most difficult aspect of the entire science. Subtract a few dollars here and there, maybe, but still all good.
I have been puzzling myself about the diversification of CBAI into DNA testing. The medical community I am a part of is in a quandry about the type of DNA testing offered by CBAI. On the one hand, awesome technology available to the general public. The reality is that many people simply don't want to know what their future health care footprint looks like. There are so many genetic tests available to patients (often not covered by insurance companies, I might add) and patients more or less feel "spooked" at the possibility of looking in their futuristic mirror. Even genetic testing for patients diagnosed with breast cancer to determine most effective treatment, rattles a few (believe it or not). It seems to be a case of societal mindset catching up to available technology. So my question to you is simple, despite my babbling... What do you think of this new venture by CBAI?